Figure 1 (Image 01)
Eptifibatide Injection, Solution
Product Images NDC 67457-629
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 67457-629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Image 02)
Carton-20 mg (Image 03)
This text contains information about the medication Eptifibatide, which is available in a 10 ml vial containing 20 mg of the drug per mL for weight-adjusted bolus dosing. Each mL of the medication contains 2 mg Eptifibatide along with 5.25 mg citric acid in water, adjusted to a pH level of 5.35 with sodium hydroxide. The usual dose of the drug should be seen by referring to the accompanying package insert, and any unused portions of the medication should be discarded. The drug must be stored refrigerated at 2° to 8°C (36° to 46°F), and may be stored for up to 2 months at 25°C (77°F) after which it must also be discarded if unused. It is important to protect the drug from light until administration and to retain it in the carton until it is used. This medication is manufactured in India by Mylan pharmaceuticals and should only be used for intravenous use. There are also some numerical codes present but their purpose is unclear from this text.*
Carton-75 mg (Image 04)
This text is a description of a pharmaceutical product that comes in a single-dose vial. The vial contains a solution of 0.75 mg eptifibatide, 5.25 mg citric acid in water made for injection, and is intended for intravenous use only. It includes instructions for storage at refrigerated temperatures, and the requirement to discard any unused portion left in the vial. This product is manufactured by Mylan Institutional LLC, and further information may be found on Mylan.com.*
Carton-200 mg (Image 05)
This is a medication label for Eptifibatide injection, to be used intravenously. It contains 2mg of Eptifibatide and 5.25mg of citric acid in water for injection and is to be kept refrigerated at 2-8°C. The usual dose instructions are given in an accompanying package insert. The product can be transferred to room temperature for up to 2 months before use, but it must be discarded if not used within that time period. The label also provides the manufacturer's information along with codes and regulatory instructions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
